Detected ·
Airway Therapeutics
$50M—
Airway Therapeutics closed a $50M Series E-2 equity round to advance late-stage clinical development of zelpultide alfa for bronchopulmonary dysplasia (BPD) prevention in preterm infants.
- Website
- www.airwaytherapeutics.com
- Amount
- $50 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-08-26 12:04:07 UTC
- Signal ID
- 0d10883c-08f6-4c48-89e6-2bdccf0b7e7b
As the API returns it
{
"id": "0d10883c-08f6-4c48-89e6-2bdccf0b7e7b",
"created_at": "2026-08-26T12:04:07.732558Z",
"company_name": "Airway Therapeutics",
"company_website_url": "www.airwaytherapeutics.com",
"company_linkedin_url": "https://www.linkedin.com/company/airway-therapeutics",
"event_type": "funding",
"funding_amount": 50000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Airway Therapeutics closed a $50M Series E-2 equity round to advance late-stage clinical development of zelpultide alfa for bronchopulmonary dysplasia (BPD) prevention in preterm infants.*"
}